Replimune Group, Inc.
Long
Mis à jour

REPL - long - bottom play - lots of block buys

184
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

This is not a financial advice!

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

Massive block buys!

We need to break 9.0.

Keep an eye on 13.0 level, needs to get broken for a further upmove. You can take partial profits at this level if u want to lock in gains.

SL under 5.7

TP approx. 15.0

Most info on the chart.

Trade carefully!
Note
05:30:27PM
REPL
Block Trade: REPL 635,800 @ $8.53
Signals
Tuesday March 12, 2024
06:28:24PM
REPL
Block Trade: REPL 911,100 @ $8.70

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.